Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Products
- V.HEART Trials
  Configure, run and analyse virtual clinical trials on the cloud
- V.HEART Discovery
  Select candidates with human QT prolongation
Technology
About Us
Newsroom

Contact us

Products
- V.HEART Trials
  Configure, run and analyse virtual clinical trials on the cloud
- V.HEART Discovery
  Select candidates with human QT prolongation
Technology
About Us
Newsroom

Contact us

Back

Articles

•

November 25, 2025

Protected: Virtual Human Global Summit II – Resources

Protected: Virtual Human Global Summit II – Resources

Table of contents

This content is password-protected. To view it, please enter the password below.

Password:

Products
- V.HEART Trials
- V.HEART Discovery
Technology
About Us
Newsroom

We’re located at

Spain

ELEM Biotech SL
NIF B-67260281
Pier07 - Via Laietana, 26
4th Floor, Office B
08003 Barcelona, Spain
contact@elem.bio

United Kingdom

ELEM Biotech SL
Engine Shed - SetSquared
Station Approach - Bristol Temple Meads
Bristol BS1 6QH - United Kingdom
(+44) 117 903 1100
(UK Office)
contact@elem.bio

Follow us on:

© 2026 ELEM Biotech SL. All rights reserved

Legal Notice
Privacy Policy
Cookies Policy